Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Conflicts of Interest None declared. Data Availability Statement Synthetic data based on the real case study and simulated data are openly available at the GitHub repository veronicaballerini/discontinuation at https://github.com/veronicaballerini/discontinuation. Open Research Badges This article has earned an Open Data badge for making publicly available the digitally-shareable data necessary to reproduce the reported results. The data is available in the section.
Conflicts of Interest The authors declare no conflicts of interest. References 1 ICH, Statistical Principles for Clinical Trials E9 (International Council for Harmonisation, 1998). 2 EMA, Guideline on Adjustment for Baseline Covariates in Clinical Trials (Committee for Medicinal Products for Human Use, 2015). 3 FDA, Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products. Guideline for Industry (FDA, 2023).
Summary Background Human cystic and alveolar echinococcosis are among the priority neglected zoonotic diseases for which WHO advocates control. The incidence of both cystic echinococcosis and alveolar echinococcosis has increased substantially in the past 30 years in Kyrgyzstan.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
